InvestLog
MEDP Medpace Holdings, Inc. logo

MEDP Medpace Holdings, Inc.

Healthcare
$432.80+0.63%ClosedMarket Cap: $12.36B

As of 2026-05-25

Valuation

View Details

P/E (TTM)

31.99

PEG

2.77

P/B

20.58

P/S

4.62

EV/EBITDA

20.44

DCF Value

$422.32

FCF Yield

6.0%

Div Yield

0.0%

Margins & Returns

Gross Margin

29.1%

Operating Margin

21.0%

Net Margin

17.2%

ROE

120.9%

ROA

21.6%

ROIC

56.1%

Financials

View All
PeriodRevenueNet IncomeEPS
Q1 null$706.6M$123.9M$—
Q4 null$708.5M$135.1M$—
FY null$2.53B$451.1M$—
Q3 null$659.9M$111.1M$—

Analyst Ratings

View All

Consensus

Hold

Target (Consensus)

$498.86

Target (Median)

$484.00

Target Range

$400.00 - $582.00

1 Strong Buy3 Buy8 Hold0 Sell1 Strong Sell
RBC CapitalOutperform
2026-04-24
BMO CapitalMarket Perform
2026-04-24
BairdOutperform
2026-04-24
BarclaysEqual Weight
2026-04-24
BarclaysEqual Weight
2026-03-06

Trading Activity

Insider Trades

View All
Zander Dani S.director
SellMon May 18
McCarthy Cornelius P. IIIdirector
SellMon May 18
Kraft Robert O.director
SellMon May 18
Gwadry-Sridhar Femida H.director
SellMon May 18
DAVENPORT FRED B JRdirector
SellMon May 18

Related AI Research

Top LoserApr 24, 2026

MEDP drops 22.6%: why Medpace Holdings, Inc. fell today

Medpace Holdings (MEDP) posted the sharpest single-session decline among large-cap stocks across U.

Latest News

Did You Lose Money Investing in Medpace Holdings Inc.? Robbins LLP Urges Investors with Significant Losses to Contact the Firm for Information About Their Rights Against MEDPGlobeNewsWire · Tue Apr 14

Company Info

Sector

Healthcare

Industry

Medical - Diagnostics & Research

Country

US

Exchange

—

Beta

1.19

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.

Peers

CNC logoCNCDGX logoDGXHOLX logoHOLXICLR logoICLRILMN logoILMNSNN logoSNNTEM logoTEMTHC logoTHCWAT logoWATWST logoWST